MENU
+Compare
SOPH
Stock ticker: NASDAQ
AS OF
Sep 24, 04:02 PM (EDT)
Price
$3.76
Change
-$0.20 (-5.05%)
Capitalization
267.62M

SOPH SOPHiA GENETICS SA Forecast, Technical & Fundamental Analysis

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research... Show more

SOPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SOPH with price predictions
Sep 23, 2025

SOPH sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for SOPH moved above the 200-day moving average on August 22, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 19, 2025. You may want to consider a long position or call options on SOPH as a result. In of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SOPH just turned positive on September 22, 2025. Looking at past instances where SOPH's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

SOPH moved above its 50-day moving average on September 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SOPH advanced for three days, in of 195 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for SOPH crossed bearishly below the 50-day moving average on September 08, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SOPH broke above its upper Bollinger Band on September 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.489) is normal, around the industry mean (21.937). P/E Ratio (0.000) is within average values for comparable stocks, (84.015). SOPH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.869). Dividend Yield (0.000) settles around the average of (0.060) among similar stocks. P/S Ratio (3.795) is also within normal values, averaging (68.496).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SOPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SOPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SOPH is expected to report earnings to fall 39.39% to -20 cents per share on November 11

SOPHiA GENETICS SA SOPH Stock Earnings Reports
Q3'25
Est.
$-0.20
Q2'25
Missed
by $0.11
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.02
Q3'24
Missed
by $0.06
The last earnings report on August 05 showed earnings per share of -33 cents, missing the estimate of -21 cents. With 11.51K shares outstanding, the current market capitalization sits at 267.62M.
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
La Pièce 12
Phone
+41 216941060
Employees
449
Web
https://www.sophiagenetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PUTKY32.980.30
+0.92%
PT United Tractors
CSNVY20.50N/A
N/A
Corbion NV
DSKYF23.20N/A
N/A
Daiichi Sankyo Co., Ltd.
PCQRF0.06N/A
N/A
Petrolympic, Ltd.
ELRRF0.84-0.05
-5.83%
Eloro Resources Ltd.

SOPH and Stocks

Correlation & Price change

A.I.dvisor tells us that SOPH and GMGI have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SOPH and GMGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOPH
1D Price
Change %
SOPH100%
+0.76%
GMGI - SOPH
29%
Poorly correlated
-0.97%
MANH - SOPH
24%
Poorly correlated
-0.97%
SDGR - SOPH
24%
Poorly correlated
-3.35%
PGNY - SOPH
24%
Poorly correlated
-2.98%
PSFE - SOPH
24%
Poorly correlated
-3.00%
More

Groups containing SOPH

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOPH
1D Price
Change %
SOPH100%
+0.76%
Health Services
category (438 stocks)
21%
Poorly correlated
-0.26%
Services to the Health Industry
category (95 stocks)
14%
Poorly correlated
-0.72%